Used primarily in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds. Its structure supports the development of agents targeting central nervous system disorders and inflammatory conditions. The compound's pyrazole core combined with the methylamine side chain enhances binding affinity to certain enzyme receptors, making it valuable in optimizing drug candidates for improved metabolic stability and selectivity. It is also employed in the preparation of novel kinase inhibitors and cannabinoid receptor modulators during early-stage drug discovery.